Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
- 1 July 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9122) , 87-92
- https://doi.org/10.1016/s0140-6736(98)85010-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Multicenter Aspirin and Ticlopidine Trial After Intracoronary Stenting in High Risk PatientsJournal of the American College of Cardiology, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventionsAmerican Heart Journal, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Subacute stent thrombosis: Evolving issues and current conceptsJournal of the American College of Cardiology, 1996
- Platelet Function in Acute Myocardial Infarction Treated With Direct AngioplastyCirculation, 1996
- The Stentor and the sea changeThe American Journal of Cardiology, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988